Management of Parkinson's disease - Strategies, pitfalls, and future directions

被引：5
|
作者：
Hermanowicz, N
机构：
[1] Univ Calif Irvine, Coll Med, Dept Neurol, Irvine, CA 92697 USA
[2] Univ Calif Irvine, Coll Med, Movement Disorders Program, Irvine, CA 92697 USA
[3] Eisenhower Med Ctr, Phillip & Carol Traub Parkinsons Ctr, Rancho Mirage, CA USA
来源：
POSTGRADUATE MEDICINE | 2001年 / 110卷 / 06期
关键词：
D O I：
10.3810/pgm.2001.12.1060
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
As the population ages, the incidence of Parkinson's disease is likely to increase. Unfortunately, the diagnosis can be complex, and current treatment options offer symptomatic relief in many patients but no cure for the underlying neurodegeneration. In this article, Dr Hermanowicz offers a concise overview of possible etiologic factors, clinical features, treatment principles and practice, and new therapeutic approaches that may improve management of Parkinson's disease in the future.
引用
收藏
页码：15 / +
页数：8
相关论文
共 50 条
  • [1] Levodopa/dopamine replacement strategies in Parkinson's disease - Future directions
    Olanow, C. Warren
    [J]. MOVEMENT DISORDERS, 2008, 23 : S613 - S622
  • [2] Future directions in the treatment of Parkinson's disease
    Schapira, Anthony H. V.
    [J]. MOVEMENT DISORDERS, 2007, 22 : S385 - S391
  • [3] Future Directions for Developing Non-dopaminergic Strategies for the Treatment of Parkinson's Disease
    van Wamelen, Daniel J.
    Leta, Valentina
    Chaudhuri, K. Ray
    Jenner, Peter
    [J]. CURRENT NEUROPHARMACOLOGY, 2024, 22 (10) : 1606 - 1620
  • [4] Apomorphine therapy in Parkinson's disease and future directions
    Titova, Nataliya
    Chaudhuri, K. Ray
    [J]. PARKINSONISM & RELATED DISORDERS, 2016, 33 : S56 - S60
  • [5] Inpatient Management of Parkinson Disease: Current Challenges and Future Directions
    Oguh, Odinachi
    Videnovic, Aleksandar
    [J]. NEUROHOSPITALIST, 2012, 2 (01): : 28 - 35
  • [6] Levodopa-Induced Dyskinesias in Parkinson's Disease: An Overview on Pathophysiology, Clinical Manifestations, Therapy Management Strategies and Future Directions
    di Biase, Lazzaro
    Pecoraro, Pasquale Maria
    Carbone, Simona Paola
    Caminiti, Maria Letizia
    Di Lazzaro, Vincenzo
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (13)
  • [7] Future Strategies for Neuroprotection in Parkinson's Disease
    Schapira, Anthony H. V.
    [J]. NEURODEGENERATIVE DISEASES, 2010, 7 (1-3) : 210 - 212
  • [8] Probiotics for Parkinson's disease: Current evidence and future directions
    Tan, Ai Huey
    Hor, Jia Wei
    Chong, Chun Wie
    Lim, Shen-Yang
    [J]. JGH OPEN, 2021, 5 (04): : 414 - 419
  • [9] Status and future directions of clinical trials in Parkinson's disease
    Soderbom, Grazyna
    [J]. METABOLIC AND BIOENERGETIC DRIVERS OF NEURODEGENERATIVE DISEASE: NEURODEGENERATIVE DISEASE RESEARCH AND COMMONALITIES WITH METABOLIC DISEASES, 2020, 154 : 153 - 188
  • [10] Subtypes of Parkinson's disease: state of the field and future directions
    Marras, Connie
    [J]. CURRENT OPINION IN NEUROLOGY, 2015, 28 (04) : 382 - 386
12345